Abstract Targeted lung delivery of therapeutics is critical for various respiratory diseases. However, the rational design of lung-targeting nanocarriers through fine-tuning of polymeric structures remains challenging. Herein, we reported the development of lung-targeting, heteropolypeptide-grafted nanoparticles (NPs), whose targeting ability was dependent on the copolymer sequence that mediated in situ erythrocyte hitchhiking.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile